DAVID GROGAN: Open Payments
NPI 1841294386 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 13 payments from 6 companies in 2025. Trend: 2023 $290 · 2024 $269 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Harrow Eye, LLC | 3 | $185 |
| Bausch & Lomb Americas Inc. | 5 | $150 |
| Tarsus Pharmaceuticals, Inc. | 2 | $52 |
| ABBVIE INC. | 1 | $28 |
| Novo Nordisk Inc | 1 | $24 |
| Dompe US, Inc. | 1 | $18 |
Products named: VEVYE, MIEBO, XDEMVY, LUMIGAN, Ozempic, OXERVATE, XIIDRA.
Industry payments across GA — which companies pay providers there.
